G
M 2
gangliosidosis,
type I (Tay-Sachs
disease; see text)
Gyi
2
~
anc*
desialo-
GM
2
'g angliosides
Other desialo hexosyl
ceramides accumulate; other
compunds occasionally.
Metachromatic
leukodystrophy (MLD;
sulfatide lipidoses; at
least three types; see text)
3-sulfate-galacto-
sylcerebroside
Cerebrosides other than
sulfatides are decreased;
ceramide dihexoside sulfate
accumulates.
Krabbe’s disease
(globoid cell
leukodystrophy; galactosyl
ceramide lipidosis)
Galactocerebroside
Salfatides are also greatly
decreased, probably as a
secondary feature.
*The circled numbers refer to reactions in Figure 19-8. The abbreviations are the same as in that figure.
Hexosaminidase A ((D)
Sulfatidases (©);
arylsulfatases)
Activator protein sap-B
Galactocerebroside-
/3-galactosidase ((D)
Red spot in retina; mental
retardation; severe
psychomotor retardation;
seizures; blindness; startle
response to sound; invariably
fatal; autosomal recessive;
panracial but especially
prevalent among Northern
European Jews.
Demyelination; progressive
paralysis and dementia; death
usually occurs within the first
decade; autosomal recessive
inheritance.
Mental retardation;
demyelination; psychomotor
retardation; failure to thrive;
progressive spasticity; globoid
cells in brain white matter;
invariably fatal; autosomal
recessive inheritance.
previous page 443 Bhagavan Medical Biochemistry 2001 read online next page 445 Bhagavan Medical Biochemistry 2001 read online Home Toggle text on/off